Apollon Wealth Management LLC Has $539,000 Stock Position in Mettler-Toledo International Inc. (NYSE:MTD)

Apollon Wealth Management LLC lessened its position in Mettler-Toledo International Inc. (NYSE:MTD) by 6.8% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 359 shares of the medical instruments supplier’s stock after selling 26 shares during the period. Apollon Wealth Management LLC’s holdings in Mettler-Toledo International were worth $539,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently modified their holdings of MTD. PineStone Asset Management Inc. grew its position in Mettler-Toledo International by 127.4% in the 2nd quarter. PineStone Asset Management Inc. now owns 259,629 shares of the medical instruments supplier’s stock valued at $362,855,000 after purchasing an additional 145,453 shares during the period. Capital International Investors grew its holdings in shares of Mettler-Toledo International by 15.1% during the first quarter. Capital International Investors now owns 1,075,420 shares of the medical instruments supplier’s stock valued at $1,431,696,000 after buying an additional 141,431 shares during the last quarter. International Assets Investment Management LLC increased its position in shares of Mettler-Toledo International by 149,870.0% during the third quarter. International Assets Investment Management LLC now owns 89,982 shares of the medical instruments supplier’s stock worth $134,946,000 after acquiring an additional 89,922 shares in the last quarter. Price T Rowe Associates Inc. MD raised its holdings in shares of Mettler-Toledo International by 88.3% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 122,655 shares of the medical instruments supplier’s stock worth $163,290,000 after acquiring an additional 57,509 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA lifted its position in Mettler-Toledo International by 32.5% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 142,944 shares of the medical instruments supplier’s stock valued at $199,777,000 after acquiring an additional 35,048 shares in the last quarter. Institutional investors own 95.07% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently commented on MTD shares. Stifel Nicolaus lowered their price objective on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research note on Monday, November 11th. Evercore ISI increased their price target on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an “in-line” rating in a research report on Tuesday, October 1st. Robert W. Baird cut their price objective on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating on the stock in a report on Monday, November 11th. JPMorgan Chase & Co. upped their target price on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the stock a “neutral” rating in a research note on Monday, August 5th. Finally, Wells Fargo & Company dropped their price target on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a research report on Monday, November 11th. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, Mettler-Toledo International has an average rating of “Hold” and a consensus target price of $1,338.75.

Insider Buying and Selling

In other Mettler-Toledo International news, Director Elisha W. Finney sold 76 shares of the stock in a transaction dated Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the completion of the transaction, the director now owns 240 shares in the company, valued at $314,820. This trade represents a 24.05 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.94% of the stock is currently owned by insiders.

Mettler-Toledo International Stock Performance

Shares of MTD stock opened at $1,179.58 on Friday. Mettler-Toledo International Inc. has a 52 week low of $1,041.49 and a 52 week high of $1,546.93. The firm’s 50-day simple moving average is $1,382.02 and its two-hundred day simple moving average is $1,400.14. The firm has a market cap of $24.89 billion, a price-to-earnings ratio of 31.80, a P/E/G ratio of 4.16 and a beta of 1.16.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $10.21 EPS for the quarter, beating the consensus estimate of $10.00 by $0.21. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. The business had revenue of $954.54 million for the quarter, compared to the consensus estimate of $941.93 million. Analysts forecast that Mettler-Toledo International Inc. will post 40.37 earnings per share for the current year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.